CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Education EDU
Support efforts to strengthen K-12, undergraduate and post-graduate science, technology, engineering, and math (STEM) education. H.R. 6104, to provide for the coordination of the Nation's science, technology, engineering, and mathematics education initiatives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Medical/Disease Research/Clinical Labs MED
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, provisions on NIH and biodefense/pandemic funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Taxation/Internal Revenue Code TAX
Provisions within stimulus proposals and legislation allowing companies accelerated use of tax assets, such as net operating losses or research and development credits.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Health Issues HCR
Support legislation (H.R. 5269 and H.R. 1956) to provide for the approval of follow-on biologics (FOBs) that recognizes the complexity of large molecule product development and manufacturing, emphasizes patient safety, and contains adequate incentives for continued innovation. Address concerns with application of comparative effectiveness research as a blunt cost containment tool and the consequences to biomedical innovation and patient access. Oppose removal of medical device preemption provision from existing statute. Support legislation enacting a uniform federal pedigree standard for prescription drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Medicare/Medicaid MMM
H.R. 1321, Medicare Advanced Laboratory Diagnostics Act of 2007; H.R. 5765, to amend title XVIII of the Social Security Act to cover remote patient management services for certain chronic health conditions under the Medicare Program; address the consequences of the inappropriate applications of comparative effectiveness research when used simply as a cost containment mechanism.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Budget/Appropriations BUD
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, provisions on NIH and biodefense/pandemic funding, and math and science education program funding. Commerce, Justice, Science Appropriations, provisions on funding for NSF and for Professional Science Masters program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.